Clinical Trials Browser

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT05112666 2023-04-03

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Completed

2,601 enrolled

Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05461807 2022-10-26

H2H-OSCAR-US

Completed

2,437 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Phase NA Completed

27 enrolled 8 charts

Neoplasms, Venous Thrombosis

NCT05303818 2022-03-31

Ésquilo

Phase 4 Unknown

68 enrolled

Gastrointestinal

Colonic Neoplasms, Venous Thrombosis

NCT03055026 2022-03-11

PRO-LAPSII

Phase 3 Completed

582 enrolled

Classical hematology

Prevention of Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Completed

97,765 enrolled

Classical hematology

Venous Thromboembolism

NCT04999176 2021-08-10

VALERIA

Phase 3 Unknown

440 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

246 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT04192916 2021-02-21

MPN-DOACs

Completed

442 enrolled

Myeloid

Myeloproliferative Disorders

NCT04256525 2020-06-30

Prophylactic Anticoagulation for Catheter-related Thrombosis

Phase 4 Unknown

1,640 enrolled

Tumor-Agnostic

Neoplasms

NCT04309240 2020-03-16

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Phase 3 Unknown

204 enrolled

Neoplasms, Venous Thrombosis

NCT03139487 2020-01-06

PRIORITY

Phase 2 Unknown

176 enrolled

GastrointestinalSarcoma

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Phase 3 Completed

841 enrolled 24 charts

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Completed

695 enrolled

Neoplasms, Pulmonary Embolism

NCT03282643 2019-04-16

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Phase 1/2 Completed

74 enrolled

Tumor-Agnostic

Neoplasms

NCT03214172 2018-09-06

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Completed

1,000 enrolled

Classical hematology

Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

159 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Phase 4 Completed

127 enrolled

Hemorrhage, Recurrence

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Phase 4 Completed

70 enrolled

Neoplasms, Upper Extremity Deep Vein Thrombosis

Clinical Trials

VICTORIE

HEM-DOAC

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

PREVENT-GU

TRIM-Line

OSCAR-US

GynCAT

TRIM-Line

ROSIE

RithMM

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

COSIMO

CAT_PB

CANVAS

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

H2H-OSCAR-US

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Ésquilo

PRO-LAPSII

PRACTISE

VALERIA

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

MPN-DOACs

Prophylactic Anticoagulation for Catheter-related Thrombosis

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

PRIORITY

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

CASTA-DIVA

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)